CVU October early bird registrations closing soon!
Early bird registrations for our annual Clinical Vaccinology Update (CVU) on Friday 28th October are closing soon!
Our face-to-face event will provide professional development delivered via keynote sessions and interactive breakouts, as well as the opportunity to connect and network with peers.
Register now and don’t miss this opportunity to hear from leading experts on the latest developments and trends in immunisation.
To see the program and to register, please click on the link below to our Events page.
MVEC: Clinical Vaccinology Update (CVU) 2022
World-first real-time safety data for JYNNEOS monkeypox vaccine available from AusVaxSafety
Newly published AusVaxSafety surveillance data of more than 1,300 first doses of JYNNEOS® has revealed that 54% of vaccinees experienced no side effects in the first 7 days following vaccination. Of the vaccinees reporting symptoms, side effects were commonly mild and short lived and included local reactions, fatigue, headache and muscle/joint pain.
In order to inform further guidance around the use of JYNNEOS® in Australia, AusVaxSafety will continue to collect and publish this information, including side effects following dose 2.
To read the update in full, please click on the link below.
World-first real-time safety data for JYNNEOS monkeypox vaccine available from AusVaxSafety
Join the waitlist for MVEC’s Immunisation Skills Workshop – Friday 25 November 2022
Registrations for MVEC’s Immunisation Skills Workshop taking place on Friday 25th November are now at capacity! If you missed out on registering for the session, we invite you to join our waitlist by emailing [email protected], and should a spot become available we will contact you to register.
The full-day interactive, face-to-face workshop is MVEC’s newest education opportunity designed to provide education and upskilling in the principles and processes of managing:
- effective vaccine communication
- error prevention and management
- anaphylaxis and acute stress responses.
Participants will hear from immunisation experts and have the opportunity to engage in simulated scenarios.
For more information, please click on the link below to our events page.
MVEC: Immunisation Skills Workshop
A recording of the 30th August CVU mini is now available
Thank you to all who attended our recent CVU miniseries event COVID-19: infection and vaccines in children aged 6 months and over on Tuesday 30th August 2022.
This interactive webinar provided an update on:
- COVID-19 infection in children over 6 months: The Melbourne experience
- COVID-19 vaccine recommendations for Australian children over 6 months
- The safety profile of COVID-19 vaccines in children
A recording of this event is now available via our education portal.
To access this recording please follow the link below:
Registrations now open for the Clinical Vaccinology Update (CVU) 2022!
Registrations are now open for the annual Clinical Vaccinology Update (CVU), taking place in person on Friday 28th October.
Our face-to-face event will provide professional development delivered via keynote sessions and interactive breakouts, as well as the opportunity to connect and network with peers.
Register now and don’t miss this opportunity to hear from leading experts on the latest developments and trends in immunisation.
To find out more about the program and to register, please click on the link below to our Events page.
MVEC: Clinical Vaccinology Update (CVU) 2022
ATAGI recommendations on the use of the Novavax vaccine for adolescents aged 12-17 years
ATAGI have now recommended that adolescents aged 12-17 years can receive the Novavax COVID-19 vaccine for their primary course of COVID-19 vaccination. This recommendation provides another vaccine brand option, in addition to Pfizer and Moderna, for individuals in this age group.
A Novavax primary schedule consists of 2 doses, administered 8 weeks apart. Those with severe immunocompromise should receive 3 doses.
Whilst Novavax is not currently registered for use as a booster dose in adolescents aged 12-17 years, ATAGI advises that it may be used for this purpose, when Pfizer is not suitable for that person.
To read the recommendations in full please follow the link below.
ATAGI recommendations on the use of the Novavax vaccine for adolescents aged 12-17 years.
Vaccines Work GAVI: Five charts on monkeypox, past and present
Despite the first cases of monkeypox infection in humans being reported in the 1970’s, previous outbreaks of disease have been relatively small compared with the international outbreak we are currently experiencing. Human to human transmission has been historically uncommon with cases limited to smaller geographical regions. Current rates of infection, with extensive human to human transmission and wide global spread has led this outbreak to be a very unique scenario.
The following article uses the latest data to explore the current rates of infection across different demographics and regions, the impact of pre-existing medical conditions, as well as vaccine access and severity of disease.
To read the article in full, click on the link below.
Vaccines Work GAVI: Five charts on monkeypox, past and present
To view our reference page on monkeypox, click on the link below.
MVEC: Monkeypox
Recording of the VACSIG webinar now available
A webinar recording is now available from the recent Vaccination Special Interest Group (VACSIG) event on Wednesday 17 August. The topic for the webinar was Monkeypox & smallpox vaccines: an Australian perspective, and featured a panel of expert speakers including MVEC’s A/Prof Nigel Crawford.
To view the recording, please click on the link below.
VACSIG Webinar 17 August
Registrations now open for MVEC’s Immunisation Skills Workshop – Friday 25 November 2022
MVEC are pleased to announce that registrations for our Immunisation Skills Workshop taking place on Friday 25th November are now open.
The full day interactive, face to face workshop is MVEC’s newest education opportunity designed to provide education and upskilling in the principles and processes of managing:
- effective vaccine communication
- error prevention and management
- anaphylaxis and acute stress responses.
Participants will hear from immunisation experts and have the opportunity to engage in simulated scenarios.
The workshop will account for 12 nursing CPD hours and up to 24 points of CPD for pharmacist immunisers (including preparation and reading time).
Venue: The HELP Precinct, The Royal Children’s Hospital, 50 Flemington Road, Parkville
Time: 8:30am – 4:30pm
Cost: $290.00 (including catering)
Register for the Immunisation Skills Workshop now via the link below!
MVEC Immunisation Skills Workshop
Registrations now open for the August CVU mini event
MVEC’s next Clinical Vaccinology Update (CVU) mini event on COVID-19: infection and vaccines in children aged 6 months and over will take place virtually on Tuesday 30th August. This CVU mini will provide an update on:
- COVID-19 vaccine recommendations for Australian children over 6 months
- The safety profile of COVID-19 vaccines in children
- COVID-19 vaccine rollout logistics
The event program and link to register will be available shortly via our Events page or via the link below.